It is a agriculture private limited company based in Mumbai, Maharashtra, India, established in 2011.
2011 | Mumbai, Maharashtra, India | ActiveDhanwantri Bioremedies Private Limited, a active private limited company, was established on 06 July 2011 in Mumbai, Maharashtra, India. Engaging in agri support services within the manufacturing sector, it holds CIN: U01120MH2011PTC219488. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹1.82 Cr.
Formerly known as Victory Herbals Private Limited. It upholds a compliant status. Its leadership includes Nagendra Rupaji Deoke (Director), Nitin Dasharath Devke (Additional Director). Past directors included Raghvendra Kumar Singh, Nitin Dattatraya Mamidwar, Pramod Jasraj Bharal. Its latest AGM occurred on 30 September 2022, with the balance sheet filed on 31 March 2022. It is based at 312, The Jewel, Roxy Building, Near Panchratna Building, Opera House,, Mumbai, Maharashtra, 400004.
U01120MH2011PTC219488
219488
06 July 2011
₹2.00 Cr
₹1.82 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Dhanwantri Bioremedies Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nagendra Rupaji Deoke | Director | 02 May 2017 | Current |
| Nitin Dasharath Devke | Additional Director | 03 Apr 2023 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 05 Oct 2013 | Past |
| Pramod Abcsdd | Managing Director | 03 Jul 2021 | Past |
| Pramod Abcsdd | Additional Director | 03 Apr 2023 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2017 | Past |
| Pramod Abcsdd | Additional Director | 01 Nov 2022 | Past |
| Pramod Abcsdd | Director | 30 Aug 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Dhanwantri Bioremedies Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 18.09% increase. The company also saw a substantial fall in profitability, with a 139.74% decrease in profit. The company's net worth Soared by an impressive increase of 897.59%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Dhanwantri Bioremedies had a promoter holding of 99.01% and a public holding of 0.99%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Dhanwantri Bioremedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Dhanwantri Bioremedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dhanwantri Bioremedies's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Nitin Dasharath Devke was appointed as a Additional Director was appointed as a Additional Director on 03 Apr 2023 & has been associated with this company since 2 years 7 months . was completed.
Dhanwantri Bioremedies Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records. was recorded as a recent event.
Progress on Dhanwantri Bioremedies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Mumbai. was documented.
Progress on Nagendra Rupaji Deoke was appointed as a Director was appointed as a Director on 02 May 2017 & has been associated with this company since 8 years 6 months . was documented.
Progress on Dhanwantri Bioremedies Private Limited was registered on 06 Jul 2011 with Roc Mumbai & aged 14 years 4 months as per MCA records. was documented.
The CIN of Dhanwantri Bioremedies Private Limited is U01120MH2011PTC219488.
Dhanwantri Bioremedies Private Limited is headquartered at 312, The Jewel, Roxy Building, Near Panchratna Building, Opera House,, Mumbai, Maharashtra, 400004.
Dhanwantri Bioremedies Private Limited was incorporated on 06 July 2011.
The current directors of Dhanwantri Bioremedies Private Limited are
The primary industry of Dhanwantri Bioremedies Private Limited is Manufacturing.
Dhanwantri Bioremedies Private Limited is unlisted.
The authorized capital of Dhanwantri Bioremedies Private Limited is ₹2.00 Cr, and the paid-up capital is ₹1.82 Cr.
The compliance status of Dhanwantri Bioremedies Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX